We are live on ! Find out more

TBRA

Tobira Therapeutics, Inc. Common Stock

TBRA

Delisted

TBRA was delisted on the 31st of October, 2016.

49 hedge funds and large institutions have $70.9M invested in Tobira Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New

Increased

Maintained

Reduced

Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

60% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 10

17% more funds holding

Funds holding: 42 → 49 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

31% less capital invested

Capital invested by funds: $103M → $70.9M (-$31.6M)

Holders

Holders Change

Holders Change %

+16.67%

% of All Funds

1.37%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.08%

New

Increased

Reduced

Closed

Calls

$179K

Puts

–

Net Calls

+$179K

Net Calls Change

-$226K

Top Buyers

Rank	Fund	Capital Flow
1	Fidelity Investments Boston, Massachusetts	+$18M
2	EAM EverPoint Asset Management Stamford, Connecticut	+$4.77M
3	SM Sabby Management Miami Beach, Florida	+$2.46M
4	Morgan Stanley New York	+$846K
5	Vanguard Group Malvern, Pennsylvania	+$645K

Top Sellers

Rank	Fund	Capital Flow
1	CPV Canaan Partners VII Westport, Connecticut	-$8.23M
2	PP Paloma Partners Greenwich, Connecticut	-$435K
3	Goldman Sachs New York	-$423K
4	Deutsche Bank Frankfurt Am Main Ge, Germany	-$314K
5	State Street Boston, Massachusetts	-$134K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	BIM 26 BlackRock Investment Management Wilmington, Delaware	$74K	-$1.53K	-109	-1%
27	27 Deutsche Bank Frankfurt Am Main Ge, Germany	$64K	-$314K	-22,361	-77%
28	TCIM 28 TIAA CREF Investment Management New York	$62K	–	–	–
29	29 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$42K	–	–	–
30	TA 30 Teachers Advisors New York	$36K	–	–	–
31	BCM 31 Blume Capital Management Berkeley, California	$33K	–	–	–
32	32 New York State Common Retirement Fund Albany, New York	$21K	–	–	–
33	AIG 33 American International Group New York	$14K	+$14	+1	+0.1%
34	BJ 34 BlackRock Japan Tokyo, Japan	$14K	+$21.1K	+1,501	New
35	35 UBS Group Zurich, Switzerland	$13K	+$17K	+1,212	+726%
36	NFA 36 Nationwide Fund Advisors Columbus, Ohio	$12K	–	–	–
37	TRCT 37 Tower Research Capital (TRC) New York	$9K	+$2.08K	+148	+19%
38	SO 38 STRS Ohio Columbus, Ohio	$5K	–	–	–
39	39 BNP Paribas Financial Markets Paris, France	$4.81K	+$6.99K	+498	New
40	40 Bank of America Charlotte, North Carolina	$4K	-$996	-71	-16%
41	41 Royal Bank of Canada Toronto, Ontario, Canada	$2K	+$589	+42	+22%
42	CSS 42 Cubist Systematic Strategies Stamford, Connecticut	$2K	+$2.5K	+178	New
43	43 Walleye Trading New York	$2K	+$2.81K	+200	New
44	44 Citigroup New York	$1K	-$12.5K	-890	-89%
45	LTFS 45 Ladenburg Thalmann Financial Services Miami, Florida	$1K	–	–	–
46	46 PNC Financial Services Group Pittsburgh, Pennsylvania	$1K	+$28	+2	+3%
47	47 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$1	+$1.63K	+116	New
48	PP 48 Paloma Partners Greenwich, Connecticut	–	-$435K	-25,224	Closed
49	49 US Bancorp Minneapolis, Minnesota	–	-$76K	-4,400	Closed
50	50 Invesco Atlanta, Georgia	–	-$5K	-291	Closed

TBRA Hedge Fund Activity: Q3 2015 in Review

49 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q3 2015, worth a combined $70.9M — down 31% from $103M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TBRA positions and 3 closed out — a net gain of 7 holders — while 16 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $18M. The largest seller was Canaan Partners VII, cutting an estimated $8.23M.

49 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q3 2015, up from 42 in Q2 2015.
Funds reported $70.9M of Tobira Therapeutics, Inc. Common Stock stock for Q3 2015, down 31% quarter-over-quarter.
10 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q3 2015 and 3 closed out, a net change of +7 holders.
The largest Tobira Therapeutics, Inc. Common Stock buyer in Q3 2015 was Fidelity Investments, an estimated $18M added.
The largest Tobira Therapeutics, Inc. Common Stock seller in Q3 2015 was Canaan Partners VII, an estimated $8.23M sold.

Based on aggregated 13F filings for Q3 2015.

Tobira Therapeutics, Inc. Common Stock TBRA